Psoriasis vulgaris - An inflammatory skin disease and/or benign epidermal hyperplasia

Acta Dermatovenerologica Croatica

Volumn 19, Issue 2, 2011, Pages 117-119

  Čabrijan, Leo ^a   Lipozenčić, Jasna ^b   Batinac, Tanja ^a   Lenković, Maja ^a   Stanić Žgombić, Zrinka ^a   Gregurić, Sanja ^c  

^a KBC RIJEKA   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c Private Dermatovenereology Clinic   (Croatia)

Author keywords

Benign tumor; Epidermal hyperplasia; Psoriasis vulgaris

Indexed keywords

ANTIINFLAMMATORY AGENT; CD47 ANTIGEN; CYCLOSPORIN A; ETRETINATE; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ARTICLE; CLEAR CELL CARCINOMA; DISEASE ASSOCIATION; EPIDERMIS HYPERPLASIA; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PSORIASIS VULGARIS; PUVA; SKIN INFLAMMATION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET B RADIATION; VERRUCA VULGARIS;

BIOPSY, NEEDLE; DERMATITIS; DIAGNOSIS, DIFFERENTIAL; EPIDERMIS; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; PSORIASIS;

EID: 79959618748     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Khalil FK, Keehn CA, Saeed S, Morgan MB. Verrucous psoriasis: a distinctive clinicopathologic variant of psoriasis. Am J Dermatopathol 2005;27:204-7.
2. Ackerman AB. Histologic diagnosis of inflammatory skin diseases. Baltimore, Maryland: Williams & Wilkins; 1997. pp. 663-4.
3. Pašić A. Eritematoskvamozne i papulozne dermatoze. In: Lipozenčić J, et al., editors. Dermatovenerologija. Zagreb: Medicinska naklada; 2004. pp. 197-207.
4. Duvic M, Asanao A, Hager C, Mays S. The pathogenesis of psoriasis and the mechanism of action of tazarotene. J Am Acad Dermatol 1998;129:32.
5. Koga T, Duan H, Urabe K, Furue M. In situ localization of IFN-gamma-positive cells in psoriatic lesional epidermis. Eur J Dermatol 2002;12:20-3.
6. Gillitzer R, Ritter U, Spandau U, Goebeler M, Bröcker EB. Differential expression of GRO-alpha and IL- 8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. J Invest Dermatol 1996;107:778-82.
7. Paukkonen K, Naukkarinen A, Horsmanheimo M. The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes. Arch Dermatol Res 1995;287:165-70.
8. Nickoloff BJ, Mitra RS, Green J, Zheng X-G, Shimizu Y, Thompson C, et al. Accessory cell function of keratinocytes for superantigens: dependence on lymphocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. J Immunol 1993;150:2148-59.
9. Kuroda K, Sapadin A, Shoji T, Fleischmajer R, Lebwohl M. Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. J Invest Dermatol 2001;116:713-20.
10. Kobayashi H, Boelte KC, Lin PC. Endothelial cell adhesion molecules and cancer progression. Curr Med Chem 2007;14:377-86.
11. Vissers WH, Arndtz CHM, Muys L, Van Erp PEJ, Jong EMG, van de Kerkohf PCM. Memory effector (CD45RO+) and cytotoxic CD8+ T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late. Br J Dermatol 2004;150:852-9.
12. Sebök B, Bonnekoh B, Mahrle G. Il-1 alpha-induced expression of ICAM-1 on cultured hyperproliferative keratinocytes: suppression by antipsoriatic dimethyl- fumarate. Int J Dermatol 1994;33:367-70.
13. Brody I. Dermal and epidermal involvement in the evolution of acute eruptive guttate psoriasis vulgaris. J Invest Dermatol 1984;82:465-70.
14. Coven TR, Murphy FP, Gilleaudeau P, Cardinale I, Krueger JG. Trimethylpsoralen bath PUVA is a remittive treatment for psoriasis vulgaris. Evidence that epidermal immunocytes are direct therapeutic targets. Arch Dermatol 1998;134:1263-8.
15. Cabrijan L, Lipozencić J, Batinac T, Lenković M, Stanić Zgombić Z. Influence of PUVA and UVB radiation on expression of ICAM-1 and VCAM-1 molecules in psoriasis vulgaris. Coll Antropol 2008;32 (Suppl 2):53-6.
16. Cabrijan L, Batinac T, Lenkovic M, Gruber F. The distinction between lesional and non-lesional skin in psoriasis vulgaris through expression of adhesion molecules ICAM-1 and VCAM-1. Med Hypotheses 2009;72:327-9.
17. Murphy M, Kerr P, Grant-Kels JM. The histopathologic spectrum of psoriasis. Clin Dermatol 2007;25:524-8.
18. Blum A, Metzler G, Bauer J, Rassner G, Garbe C. The dermatoscopic pattern of clear-cell acanthoma resembles psoriasis vulgaris. Dermatology 2001;203:50-2.
19. Doger FK, Dikicioglu E, Ergin F, Unal E, Sendur N, Uslu M. Nature of cell kinetics in psoriatic epidermis. J Cutan Pathol 2007;34:257-63.
20. Zippin JH, Chadwick PA, Levin LR, Buck J, Magro CM. Soluble adenylyl cyclase defines a nuclear cAMP microdomain in keratinocyte hyperproliferative skin diseases. J Invest Dermatol 2010;130:1279-87.
21. Hiraiwa A, Fujita M, Adachi A, Ono H, Nagasaka T, Matsumoto Y, et al. Specific distribution patterns of hCDC47 expression in cutaneous diseases. J Cutan Pathol 1998;25:285-90.